title: Fixed dosing regimes of enoxaparin for thromboprophylaxis do not reliably achieve target anti-Xa levels in women of normal weight during pregnancy.
authors.forename: Sarah J
authors.initials: SJ
authors.lastname: Stock
authors.forename: Mairi C
authors.initials: MC
authors.lastname: Walker
authors.forename: Benjamin T
authors.initials: BT
authors.lastname: Edelshain
authors.forename: Lishel
authors.initials: L
authors.lastname: Horn
authors.forename: Jane E
authors.initials: JE
authors.lastname: Norman
authors.forename: Fiona C
authors.initials: FC
authors.lastname: Denison
mesh_terms: D000328:Adult; D000925:Anticoagulants / Q000008:administration & dosage*; D001835:Body Weight; D017984:Enoxaparin / Q000008:administration & dosage*; D015951:Factor Xa / Q000378:metabolism*; D005260:Female; D006801:Humans; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000517:prevention & control*; D012189:Retrospective Studies; D013927:Thrombosis / Q000517:prevention & control*
chemical_list: D000925:Anticoagulants; D017984:Enoxaparin; D015951:Factor Xa